Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges - Wikidata - thesis-toulmin - TriplyDB

Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges

Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges

http://www.wikidata.org/entity/Q34981433

about

Role of platelet-rich plasma in ischemic heart disease: An update on the latest evidence Bridging Basic Science with Cardiac Surgery: The Bristol Heart Institute Experience Redox regulation of stem/progenitor cells and bone marrow niche Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions Potential of cardiac stem/progenitor cells and induced pluripotent stem cells for cardiac repair in ischaemic heart disease Spheroid Culture of Mesenchymal Stem Cells Preconditioning via angiotensin type 2 receptor activation improves therapeutic efficacy of bone marrow mononuclear cells for cardiac repair Combined transplantation of mesenchymal stem cells and endothelial progenitor cells for tissue engineering: a systematic review and meta-analysis Left ventricular assist devices: current controversies and future directions.Nanovector-based prolyl hydroxylase domain 2 silencing system enhances the efficiency of stem cell transplantation for infarcted myocardium repair.Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails.Enhanced potency of cell-based therapy for ischemic tissue repair using an injectable bioactive epitope presenting nanofiber support matrix Angiotensin-(1-7) reverses angiogenic dysfunction in corpus cavernosum by acting on the microvasculature and bone marrow-derived cells in diabetes Distinct effects of unfractionated heparin versus bivalirudin on circulating angiogenic peptides.Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogramming Adenosine stimulates the migration of human endothelial progenitor cells. Role of CXCR4 and microRNA-150 The relative contribution of paracine effect versus direct differentiation on adipose-derived stem cell transplantation mediated cardiac repair.Functional neural-bone marrow pathways: implications in hypertension and cardiovascular disease.Cardiomyocyte protection by GATA-4 gene engineered mesenchymal stem cells is partially mediated by translocation of miR-221 in microvesicles.Mechanical preconditioning enables electrophysiologic coupling of skeletal myoblast cells to myocardium Pretreatment of Adipose Derived Stem Cells with Curcumin Facilitates Myocardial Recovery via Antiapoptosis and Angiogenesis.Challenges for heart disease stem cell therapy.Myocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf 'unlimited' therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study.Therapeutic manipulation of angiogenesis with miR-27b Molecular imaging of stem cells for the treatment of acute myocardial infarction Improved survival of mesenchymal stem cells by macrophage migration inhibitory factor Inhibiting Extracellular Vesicle Release from Human Cardiosphere Derived Cells with Lentiviral Knockdown of nSMase2 Differentially Effects Proliferation and Apoptosis in Cardiomyocytes, Fibroblasts and Endothelial Cells In Vitro.Targeting chronic cardiac remodeling with cardiac progenitor cells in a murine model of ischemia/reperfusion injury.Tissue engineering: construction of a multicellular 3D scaffold for the delivery of layered cell sheets Early growth response genes signaling supports strong paracrine capability of mesenchymal stem cells.Adipose-Derived Stem Cells Induce Angiogenesis via Microvesicle Transport of miRNA-31.Isolation, Characterization, and Spatial Distribution of Cardiac Progenitor Cells in the Sheep Heart.The promise and perils of stem cell therapeutics.Macrophage migration inhibitory factor promotes cardiac stem cell proliferation and endothelial differentiation through the activation of the PI3K/Akt/mTOR and AMPK pathways.Myocardial therapeutic angiogenesis: a review of the state of development and future obstacles Bone marrow endothelial progenitors in atherosclerotic plaque resolution The new biology: a bridge to clinical cardiology.Prolyl hydroxylase domain protein 2 silencing enhances the survival and paracrine function of transplanted adipose-derived stem cells in infarcted myocardium Therapeutic effects of human umbilical cord mesenchymal stem cells transplantation on hypoxic ischemic encephalopathy Myocardial regeneration by transplantation of modified endothelial progenitor cells expressing SDF-1 in a rat model.

P2860

Q26777855-D74E5232-674B-43C1-84B2-CCDAD2B1656C Q26799939-8A1BC96E-E638-440D-B3AD-C2548B02C637 Q26851313-C8E18FEB-A936-4288-96D2-758347845775 Q27001159-D1A73099-B9E9-421E-8569-950577D0F544 Q27012551-F90DC6B5-6794-429C-9A90-87B051E3B0CA Q27023276-68564755-ED41-490A-85E0-9D23798BC85B Q27341905-D801E825-15D1-4DC8-ADBB-DE7EFE24D666 Q28078267-F472430B-8D65-412C-A906-21D4AE798FB0 Q30252054-0B8BE894-EFD3-42CF-9073-3B9428EC51DD Q30601810-C0ED4F22-71A1-4501-9280-69C369296804 Q30663690-0A7F4E1C-19EC-49A2-A5E4-B57BE901997E Q34055868-E1B1897F-3B6E-4FE7-879B-DFD2DF7C814E Q34111573-DF69632F-85E0-47ED-87D3-2DF242F3E5A4 Q34235153-65EA546F-5F3F-450C-B39D-05198F9B6BA7 Q34408109-66D5F48D-77DC-48B1-AC18-FCD9A5BF06AE Q34552184-E26AA625-53C7-4D17-B1FF-63F9D3298EBB Q34634535-9FDDBCE5-9396-4D89-B916-2FBEC9B0F77C Q34972079-1924245B-625D-467A-A64B-DDD43E339C23 Q34981722-B9652EC1-4046-4822-9416-1FFFF9B87F8E Q35101764-5B791B8F-A8A2-4CF5-82FD-5233621E92A4 Q35620977-76E990CB-AF16-4C7B-86B8-55A61B7724D5 Q35808738-11AAA700-B995-4AA2-8992-A304FE525CD9 Q35829154-EF9B0A7C-FBFC-4284-80D8-134D4C653E70 Q35835060-6A789861-C19C-4184-A0BD-6448145A93A1 Q35959084-F2A9EB3A-A97C-4D11-B0F4-A8BD9FBC2412 Q35981618-EDA5123D-00E2-47C3-BC1D-8B4F3D64C984 Q36180427-A909CE63-3600-48FB-97F0-5DB03FDFBF9B Q36314795-5A1A0120-379C-405D-A0D4-AC4FDFC788E0 Q36355287-F50DF316-3BE9-4EDC-8446-8D0CAC92786A Q36486356-1EB44BF6-BE38-4C2D-AAA0-7D9D688A11E1 Q36703025-CADA4C45-C648-43FF-8E6A-43C3E730AD8B Q36713333-72E980D0-3485-4FFC-88FE-1B3EB676056B Q36776231-79E8D1C5-60F2-434B-83DF-36A992AB399C Q36791222-DDA755F9-9F0F-43AF-B4EF-D6769A5197A0 Q36820684-6B256806-C3FF-42AB-9DB3-7BC3D56AAC60 Q36906139-CDFF7A0E-E275-4E08-9D84-71CBE5F634AB Q37082703-E5EC6398-1A26-499D-AA91-2D4B0B6589AF Q37097008-ABE52424-1D0A-4DB4-A031-4E671DE7A036 Q37144147-9BF93006-A61C-4195-82CB-4B2C8718AEBD Q37296208-ABD44751-5DFB-448E-8D55-DBE743AFE10C

P2860

Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges

http://www.wikidata.org/entity/Q34981433

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Stem and progenitor cell-based ...... uncertainties, and challenges

@ast

Stem and progenitor cell-based ...... uncertainties, and challenges

@en

Stem and progenitor cell-based ...... uncertainties, and challenges

@nl

type

label

Stem and progenitor cell-based ...... uncertainties, and challenges

@ast

Stem and progenitor cell-based ...... uncertainties, and challenges

@en

Stem and progenitor cell-based ...... uncertainties, and challenges

@nl

prefLabel

Stem and progenitor cell-based ...... uncertainties, and challenges

@ast

Stem and progenitor cell-based ...... uncertainties, and challenges

@en

Stem and progenitor cell-based ...... uncertainties, and challenges

@nl

P1433

Q34981433-53A74538-F748-4B4C-B0C0-B00BE8D8BDD3

P1476

Q34981433-6F3B01C4-D7B6-4561-9154-D53BBE8B9DF2

P2093

Q34981433-D578E29C-0FBC-4648-9EBA-5317F312A70E

Q34981433-F8E3F2D6-C32D-47D7-B83D-AF3E652A7730

P2860

Q34981433-0086EDA1-8175-4FFC-8B14-AD776EAE0AE3

Q34981433-01A9F1AA-4661-464A-9A7B-21EBB9D26496

Q34981433-042AD698-CA8E-4814-9842-4B0B5FC17502

Q34981433-05E1D286-C50A-4072-88D2-33FB6609CFC7

Q34981433-0701ADFE-9A61-4929-BC20-9EF1D8B5D957

Q34981433-078377EF-9510-42A9-86F9-924D5A102BE3

Q34981433-0788666A-075D-44C5-AD8C-AC4606EFE888

Q34981433-082298CE-36D7-4586-80C3-D6C7EAC54549

Q34981433-08EE3EF1-F100-41BC-849D-A9AF1D5A7971

Q34981433-0A4343EF-6D55-409B-8352-297D463CD368

P304

Q34981433-00846332-994C-4282-B96D-819B91CC23EB

P31

Q34981433-D5DE6810-7CE7-46C4-9CC0-3847C935DBAF

P356

Q34981433-98FBEA5A-13FD-430D-8B4D-632FE1686D03

P433

Q34981433-1CB89ED4-22FB-44D3-9FC8-83ECC0FE31F9

P478

Q34981433-C2674440-8F10-4AD4-9A0B-C2FADE71B93D

P50

Q34981433-BDD6976B-B82E-49F8-AAB7-688FC0D81CEA

P577

Q34981433-EDF1E005-F3AA-4CB3-951F-63F2DBEE4DF3

P5875

Q34981433-128CEEE8-466D-43D0-BE08-C96ABBD50AB6

P698

Q34981433-E9EE2B13-7CD8-4EB0-A054-CAC7AD84EEB1

P932

Q34981433-0F0749B5-A613-41F4-A6B0-AF63EEAC10BA

P356

P1433

European Heart Journal

P1476

Stem and progenitor cell-based ...... uncertainties, and challenges

@en

P2093

Douglas W Losordo

http://www.w3.org/2001/XMLSchema#string

Jörn Tongers

http://www.w3.org/2001/XMLSchema#string

P2860

Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

Regenerating the heart

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction

Evidence for cardiomyocyte renewal in humans

Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect

Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells

In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction b

P304

1197-1206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHR018

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50249700

http://www.w3.org/2001/XMLSchema#string

P698

21362705

http://www.w3.org/2001/XMLSchema#string

P932

3094549

http://www.w3.org/2001/XMLSchema#string